Free Trial

Novo Nordisk A/S (NVO) SEC Filings & 10K Form

Novo Nordisk A/S logo
$69.61 +0.29 (+0.42%)
As of 02:29 PM Eastern

Recent Novo Nordisk A/S SEC Filings

DateFilerForm TypeView
06/26/2025
6:35 PM
Novo Nordisk A/S (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/26/2025
6:38 PM
Novo Nordisk A/S (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/13/2025
6:11 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
7:31 AM
Innate Pharma SA (Subject)
Innate Pharma SA (Subject)
Novo Nordisk A/S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2025
5:41 AM
Novo Nordisk A/S (Filer)
Form SD
Specialized Disclosure Report  
05/16/2025
7:28 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/09/2025
7:12 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2025
7:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
6:39 PM
BlackRock, Inc. (Filed by)
Novo Nordisk A/S (Subject)
Form SCHEDULE 13G/A
04/03/2025
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
6:58 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
9:09 AM
Novo Nordisk A/S (Filer)
Form IRANNOTICE
02/07/2025
7:27 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
6:36 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
6:11 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
6:18 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
6:04 AM
Novo Nordisk A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/05/2025
5:09 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
8:24 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
8:01 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
6:16 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
7:22 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2025
11:51 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
7:29 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
7:26 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
12:49 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/16/2024
7:29 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/16/2024
7:38 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
11:02 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2024
1:34 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
7:48 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
10:17 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2024
8:24 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
10:19 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
4:00 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
3:46 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Refund From 1933: Trump’s Reset May Create Instant Wealth (Ad)

Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.

Claim Your FREE Guide Now and discover how to position yourself for this golden opportunity.
11/08/2024
3:50 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
3:53 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
2:06 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2024
5:36 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
8:29 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
8:25 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:50 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
9:34 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
7:31 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:05 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2024
6:57 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
6:57 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:04 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
8:47 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
12:27 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
10:12 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
10:09 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
9:14 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
9:42 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2024
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
8:19 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
7:28 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
8:46 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
7:47 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
3:17 PM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
5:51 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
6:48 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
10:43 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
10:13 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
7:19 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
5:00 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:49 AM
Novo Nordisk A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:NVO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners